Skip to content

SOPHARMA

Active
Public limited companyfounded 200124 yrs activeJezus Eiklaan 2A, 3080 Tervuren, BelgiumKBO/BCE: BE 0476.391.546
Summary

SOPHARMA has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €167.3m and a net result of €14.3m. Equity is growing by ~22.6% per year across the filed fiscal years. Its solvency ranks better than 95% of 4238 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability29▼-42
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000,000 at 30 days acceptable
Liquidity ample (current ratio 14.29 against 4.95 in 2024; short-term debt: 1.5% and cash: 0.5% of total assets), and 2.8% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
97.2%
Return on assets
8.3%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 24 years 0 30 y
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 d early
2024
66 d early
2023
36 d early
2022
47 d early
2021
61 d late
2020
31 d late
2019
25 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 26 June (4 of the last 5 filed years within 34 days of that day).
Companies Code · seven months
Position in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

SOPHARMA was incorporated on 20 December 2001.1 Total assets rose from EUR 4.7 million in 2018 to EUR 172 million in 2025 and headcount from 2.9 to 1.5 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€14.3m▲ 1,381%
2024 · €965,281
Working capital
€34.9m▲ 1,685%
2024 · €2.0m
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result-€566,168€17,354€239,742▲ 1,281%€63,188▼ 73.6%-€168,652
Net result€2.8mabove the sector's middle half▼ 90.4%€1.4mabove the sector's middle half▼ 51.1%€1.1mabove the sector's middle half▼ 18.9%€965,281above the sector's middle half▼ 13.4%€14.3mabove the sector's middle half▲ 1,381%
Equity€50.0mabove the sector's middle half▲ 5.9%€51.4mabove the sector's middle half▲ 2.7%€52.5mabove the sector's middle half▲ 2.2%€53.5mabove the sector's middle half▲ 1.8%€167.3mabove the sector's middle half▲ 213%
Total assets€51.2mabove the sector's middle half▲ 0.2%€52.4mabove the sector's middle half▲ 2.3%€53.6mabove the sector's middle half▲ 2.3%€54.3mabove the sector's middle half▲ 1.3%€172.1mabove the sector's middle half▲ 217%
Debt€1.2m▼ 69.4%€997,688▼ 16.0%€1.1m▲ 8.1%€812,553▼ 24.7%€4.8m▲ 493%
Working capital€753,159above the sector's middle half€1.0mabove the sector's middle half▲ 36.1%€927,363above the sector's middle half▼ 9.5%€2.0mabove the sector's middle half▲ 111%€34.9mabove the sector's middle half▲ 1,685%
Solvency97.7%above the sector's middle half▲ 5.3pp98.1%above the sector's middle half▲ 0.4pp98.0%above the sector's middle half▼ 0.1pp98.5%above the sector's middle half▲ 0.5pp97.2%above the sector's middle half▼ 1.3pp
Current ratio1.98within the sector's middle half▲ 1.032.68within the sector's middle half▲ 0.702.27within the sector's middle half▼ 0.414.95above the sector's middle half▲ 2.6814.29above the sector's middle half▲ 9.34
Return on assets (ROA)5.5%within the sector's middle half▼ 51.9pp2.6%within the sector's middle half▼ 2.9pp2.1%within the sector's middle half▼ 0.5pp1.8%within the sector's middle half▼ 0.3pp8.3%within the sector's middle half▲ 6.5pp
Staff (FTE)2.5within the sector's middle half▼ 7.4%2.5within the sector's middle half=1.8within the sector's middle half▼ 28.0%2.5within the sector's middle half▲ 38.9%1.5below the sector's middle half▼ 40.0%
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Why a figure moved sharply
  • 2025 Net result +1,381% on 2024. The accounts now follow the full schema, last year the abbreviated schema.
Result per fiscal year
Operating resultNet result
-€5.0m€0€5.0m€10.0m€15.0mOperating result 2021: -€566,168-€566,168Net result 2021: €2.8m€2.8mOperating result 2022: €17,354€17,354Net result 2022: €1.4m€1.4mOperating result 2023: €239,742€239,742Net result 2023: €1.1m€1.1mOperating result 2024: €63,188€63,188Net result 2024: €965,281€965,281Operating result 2025: -€168,652-€168,652Net result 2025: €14.3m€14.3m20212022202320242025-€5m€0€5m€10m€15mOperating result 2023: €239,742€240,000Net result 2023: €1.1m€1.1mOperating result 2024: €63,188€63,200Net result 2024: €965,281€965,000Operating result 2025: -€168,652-€169,000Net result 2025: €14.3m€14m202320242025
The operating result turns negative in 2025: a loss of €168,652 after €63,188 in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €172.1m
Fixed assets €134.7m ▲ 160%
Current assets €37.5m ▲ 1,432%
Equity and liabilities €172.1m
Equity €167.3m ▲ 213%
Debt €4.8m ▲ 493%
Debt's share of the balance-sheet total rises from 1.5% to 2.8%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
-€47,788▼
2024 · €177,766
Cash flow
€14.4m▲
2024 · €1.1m
Quick ratio
14.20▲
2024 · 4.40
Debt to equity
0.03▲
2024 · 0.02
ROE
8.5%▲
2024 · 1.8%
Interest coverage
-0.06▼
2024 · 8.52
Debt ≤ 1 year
€2.6m▲
2024 · €494,248
Debt > 1 year
€2.0m▲
2024 · €306,057
Income taxes
€184,975▲
2024 · €96,837
Staff costs
€117,649▼
2024 · €145,397
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 67 lines
Balance sheet Code20242025
Assets
Total assets20/58€54.3m€172.1m▲
Fixed assets21/28€51.9m€134.7m▲
Tangible fixed assets22/27€2.8m€2.7m▼
Land and buildings22€2.7m€2.6m▼
Plant, machinery and equipment23€40,205€29,778▼
Furniture and vehicles24€19,186€13,096▼
Assets under construction and advance payments27€0-
Financial fixed assets28€49.1m€132.0m▲
Current assets29/58€2.4m€37.5m▲
Stocks and contracts in progress3€270,457€244,456▼
Stocks30/36€270,457€244,456▼
Amounts receivable within one year40/41€1.4m€4.3m▲
Trade receivables40€91,395€109,019▲
Other amounts receivable41€1.3m€4.2m▲
Current investments50/53€510,561€32.1m▲
Cash at bank and in hand54/58€271,914€836,424▲
Deferred charges and accrued income490/1€3,935€10,971▲
Equity and liabilities
Total equity and liabilities10/49€54.3m€172.1m▲
Equity10/15€53.5m€167.3m▲
Contributions10/11€16.6m€52.8m▲
Capital10€16.6m€52.8m▲
Issued capital100€16.6m€52.8m▲
Reserves13€35.1m€112.7m▲
Non-distributable reserves130/1€1.7m€2.4m▲
Legal reserve130€1.7m€2.4m▲
Tax-exempt reserves132€23,750€23,750=
Distributable reserves133€33.5m€110.3m▲
Profit (loss) carried forward14€1.8m€1.8m=
Amounts payable17/49€812,553€4.8m▲
Amounts payable after more than one year17€306,057€2.0m▲
Financial debts170/4€306,057€2.0m▲
Amounts payable within one year42/48€494,248€2.6m▲
Current portion of amounts payable after more than one year42€34,906€35,365▲
Financial debts43€137€12▼
Credit institutions430/8€137€12▼
Trade debts44€105,630€149,314▲
Suppliers440/4€105,630€149,314▲
Taxes, remuneration and social security45€223,848€221,632▼
Taxes450/3€208,049€213,577▲
Remuneration and social security454/9€15,800€8,055▼
Other amounts payable47/48€129,727€2.2m▲
Accrued charges and deferred income492/3€12,248€170,860▲
Income statement Code20242025
Non-recurring operating income76A€8,403€0▼
Remuneration, social security and pensions62€145,397€117,649▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€114,577€120,865▲
Other operating charges640/8€1,788€43,174▲
Gross operating margin9900€324,951€113,036▼
Operating profit (loss)9901€63,188-€168,652▼
Financial income75/76B€1.0m€15.9m▲
Recurring financial income75€1.0m€14.9m▲
Non-recurring financial income76B-€948,762
Financial charges65/66B€20,857€1.2m▲
Recurring financial charges65€20,857€790,860▲
Non-recurring financial charges66B-€437,442
Profit (loss) for the period before taxes9903€1.1m€14.5m▲
Income taxes67/77€96,837€184,975▲
Profit (loss) for the period9904€965,281€14.3m▲
Profit (loss) for the period to be appropriated9905€965,281€14.3m▲
Appropriation of the result
Profit (loss) to be appropriated9906€2.8m€16.1m▲
Profit (loss) brought forward from the previous period14P€1.8m€1.8m=
Transfer from equity791/2-€336,941
Transfer to equity691/2€965,000€14.3m▲
To the legal reserve6920-€714,822
To other reserves6921€965,000€13.6m▲
Profit to be distributed694/7-€336,941
Return on contributions (dividend)694-€336,941
Social balance
Average headcount (FTE)90872.51.5▼

The notes to these accounts (23 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A€0€0€180,378€8,403€0▼ 100%
Remuneration, social security and pensions62€124,606€164,209€125,193€145,397€117,649▼ 19.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€35,006€27,316€54,067€114,577€120,865▲ 5.5%
Other operating charges640/8€7,236€2,201€11,271€1,788€43,174▲ 2,314%
Non-recurring operating charges66A€638,148€0----
Gross operating margin9900€238,828€211,081€430,273€324,951€113,036▼ 65.2%
Operating profit (loss)9901-€566,168€17,354€239,742€63,188-€168,652▼ 367%
Financial income75/76B€3.5m€1.5m€1.0m€1.0m€15.9m▲ 1,457%
Recurring financial income75€3.5m€1.5m€1.0m€1.0m€14.9m▲ 1,364%
Non-recurring financial income76B€17,528€0--€948,762-
Financial charges65/66B€44,201€20,472€19,365€20,857€1.2m▲ 5,789%
Recurring financial charges65€44,201€20,472€19,365€20,857€790,860▲ 3,692%
Non-recurring financial charges66B----€437,442-
Profit (loss) for the period before taxes9903€2.9m€1.5m€1.2m€1.1m€14.5m▲ 1,263%
Income taxes67/77€100,486€137,809€116,926€96,837€184,975▲ 91.0%
Profit (loss) for the period9904€2.8m€1.4m€1.1m€965,281€14.3m▲ 1,381%
Profit (loss) for the period to be appropriated9905€2.8m€1.4m€1.1m€965,281€14.3m▲ 1,381%
Line20212022202320242025Change
Assets
Total assets20/58€51.2m€52.4m€53.6m€54.3m€172.1m▲ 217%
Fixed assets21/28€49.7m€50.8m€51.9m€51.9m€134.7m▲ 160%
Tangible fixed assets22/27€615,377€1.7m€2.9m€2.8m€2.7m▼ 4.1%
Land and buildings22€608,352€586,770€2.4m€2.7m€2.6m▼ 3.6%
Plant, machinery and equipment23€2,047€1,637€39,606€40,205€29,778▼ 25.9%
Furniture and vehicles24€4,979€1,133€30,147€19,186€13,096▼ 31.7%
Assets under construction and advance payments27-€1.1m€373,651€0--
Financial fixed assets28€49.1m€49.1m€49.1m€49.1m€132.0m▲ 169%
Current assets29/58€1.5m€1.6m€1.7m€2.4m€37.5m▲ 1,432%
Stocks and contracts in progress3€164,810€159,227€236,680€270,457€244,456▼ 9.6%
Stocks30/36€164,810€159,227€236,680€270,457€244,456▼ 9.6%
Amounts receivable within one year40/41€141,204€1.2m€761,160€1.4m€4.3m▲ 207%
Trade receivables40€67,088€70,869€74,646€91,395€109,019▲ 19.3%
Other amounts receivable41€74,116€1.1m€686,514€1.3m€4.2m▲ 220%
Current investments50/53--€500,000€510,561€32.1m▲ 6,193%
Cash at bank and in hand54/58€1.2m€290,280€154,531€271,914€836,424▲ 208%
Deferred charges and accrued income490/1€10,984€3,293€3,862€3,935€10,971▲ 179%
Equity and liabilities
Total equity and liabilities10/49€51.2m€52.4m€53.6m€54.3m€172.1m▲ 217%
Equity10/15€50.0m€51.4m€52.5m€53.5m€167.3m▲ 213%
Contributions10/11€16.6m€16.6m€16.6m€16.6m€52.8m▲ 219%
Capital10€16.6m€16.6m€16.6m€16.6m€52.8m▲ 219%
Issued capital100€16.6m€16.6m€16.6m€16.6m€52.8m▲ 219%
Reserves13€31.7m€33.1m€34.2m€35.1m€112.7m▲ 221%
Non-distributable reserves130/1€1.7m€1.7m€1.7m€1.7m€2.4m▲ 43.6%
Legal reserve130€1.7m€1.7m€1.7m€1.7m€2.4m▲ 43.6%
Tax-exempt reserves132€23,750€23,750€23,750€23,750€23,750=
Distributable reserves133€30.0m€31.4m€32.5m€33.5m€110.3m▲ 230%
Profit (loss) carried forward14€1.8m€1.8m€1.8m€1.8m€1.8m=
Amounts payable17/49€1.2m€997,688€1.1m€812,553€4.8m▲ 493%
Amounts payable after more than one year17€409,408€375,402€340,963€306,057€2.0m▲ 560%
Financial debts170/4€409,408€375,402€340,963€306,057€2.0m▲ 560%
Amounts payable within one year42/48€766,049€609,539€728,870€494,248€2.6m▲ 431%
Current portion of amounts payable after more than one year42€50,897€34,005€34,440€34,906€35,365▲ 1.3%
Financial debts43---€137€12▼ 91.3%
Credit institutions430/8---€137€12▼ 91.3%
Trade debts44€216,020€64,406€313,493€105,630€149,314▲ 41.4%
Suppliers440/4€216,020€64,406€313,493€105,630€149,314▲ 41.4%
Taxes, remuneration and social security45€180,953€258,085€263,575€223,848€221,632▼ 1.0%
Taxes450/3€163,231€238,295€257,697€208,049€213,577▲ 2.7%
Remuneration and social security454/9€17,722€19,790€5,878€15,800€8,055▼ 49.0%
Other amounts payable47/48€318,179€253,043€117,363€129,727€2.2m▲ 1,608%
Accrued charges and deferred income492/3€12,878€12,747€8,940€12,248€170,860▲ 1,295%
Line20212022202320242025Change
Profit (loss) for the period9904€2.8m€1.4m€1.1m€965,281€14.3m▲ 1,381%
+ Depreciation and write-downs630€35,006€27,316€54,067€114,577€120,865▲ 5.5%
Operating cash flow (approximation)€2.8m€1.4m€1.2m€1.1m€14.4m▲ 1,235%
Investment in fixed assets (approximation)--€1.1m-€1.2m-€22,256-€82.9m▼ 372,495%
Change in cash--€911,931-€135,749€117,383€564,510▲ 381%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial Liquidity triplescurrent ratio 14.29
Current ratio from 4.95 to 14.29.
31-12
Financial Equity above €100mEq €167.3m ▲213%
8 profitable years in a row build equity to €167.3m.
26-05
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Liquidity doublescurrent ratio 4.95
Current ratio from 2.27 to 4.95; short-term debt falls from €728,870 to €494,248.
25-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
14-06
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-09
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 61 days late
2021
31-12
Financial Liquidity doublescurrent ratio 1.98
Current ratio from 0.95 to 1.98; short-term debt falls from €766,057 to €766,049.
31-12
Financial Equity above €50mEq €50.0m ▲5.9%
4 profitable years in a row build equity to €50.0m.
31-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 31 days late
2020
31-12
Financial Highest result since 2018net €29.3m ▲11,301%
Net result €29.3m, the highest in the series.
Show earlier events
31-12
Financial Equity above €25mEq €47.2m ▲3,008%
3 profitable years in a row build equity to €47.2m.
06-07
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
19-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
28-08
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 28 days late
2017
12-07
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 10 acts read
About the unread acts

We know of 10 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 10 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Tervuren · 1 establishment unit since 2002
seat establishment The establishment unit on the map
Ground area
359 m²
Building footprint
225 m²
Volume, LiDAR
1,706 m³
Parcel 24302F0048/00V003, Flanders · tallest building 12.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK - PHARMACIE
Jezus Eiklaan 2 A, 3080 TervurenNACE 52112
since 20022.095.660.551
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24302F0048/00V003 Flanders 359 m² 1 · 225 m² 12.4 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

2 holdings

Owners 0

The accounts to 31-12-2025 list no shareholders, and no other source names one.

Holdings 2

According to the 2025 annual accounts of SOPHARMA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Subsidies and aid

Flemish government

2022 to 2023 · 2 entries · 4,000 EUR awarded · 4,000 EUR paid
Year Entries awardedpaid
2023 1 2,000 EUR2,000 EUR
2022 1 2,000 EUR2,000 EUR
Schemes
2 entries · 4,000 EUR · 4,000 EUR paid · Fonds voor Innoveren en Ondernemen

Recognitions · licences · registrations

Food safety, FASFC

1 site
Tervuren2.095.660.551
1 permission
Apotheek (LM>3 maand) · since 17-12-2014

Legal Entity Identifier

894500ONI4OZJGH40A50
live in the LEI register

Similar companies · same sector, comparable size

Of 5,219 companies in this sector we hold annual accounts for 3,862. 8 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPublic limited company
Founded20-12-2001
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47750Retail sale of cosmetics and toilet articles
Contact
E-mail sofie@sofieboone.be
E-invoicing
Reachable via Peppol
Peppol ID 0208:0476391546
Also 9925:BE0476391546
Registered 23-10-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

General meetings

1 convocation
General meeting
at the registered office · published 14-05-2009
Jaarverslag. Goedkeuring jaarrekening. Bestemming resultaat. Kwijting bestuurders. Divers. (AOPC-1-9-02688/14.05)

Scores and ratios are computed by Checked and are not a credit decision.